Shanghai Children's Hospital
Shanghai Children's Hospital
Explore linked clinical trials.15 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, nephrosis, nephrotic syndrome, urinary system disorder | Not yet recruiting | Phase 3 | 2026-08-14 | NCT07765914 | |
| A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy | Neoplasms by Histologic Type, hepatoblastoma, mixed neoplasm, neoplasm | Recruiting | Phase 3 | 2026-05-04 | NCT04478292 | |
| Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL) | T-cell Lymphoblastic Lymphoma | Recruiting | Phase 3 | 2026-03-19 | NCT05681260 | |
| Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Not stated | 2026-03-16 | NCT04794595 | |
| Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not stated | 2026-03-16 | NCT03948048 | |
| Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections | Infections | Recruiting | Not stated | 2026-02-17 | NCT04923828 | |
| RIC-NEC Randomized Controlled Trial | Digestive System Diseases, Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, digestive system disorder, enterocolitis, gastroenteritis, intestinal disorder, necrotizing enterocolitis, pregnancy disorder | Active, not recruiting | Phase 2 | 2026-02-03 | NCT05279664 | |
| Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells | Bronchiolitis Obliterans, bronchial disorder, bronchiolitis, bronchitis, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Early phase 1 | 2026-01-14 | NCT07239895 | |
| Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN） | High Risk Neuroblastoma | Active, not recruiting | Not stated | 2025-12-12 | NCT07278674 | |
| A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, bone disorder, endocrine system disorder, hereditary disease, musculoskeletal system disorder | Active, not recruiting | Phase 2 | 2025-08-15 | NCT03255694 | |
| Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, hereditary disease, pregnancy disorder, pregnancy disorder with abortive outcome | Recruiting | Not stated | 2025-02-20 | NCT04905537 | |
| Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura | Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, blood coagulation disease, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not applicable | 2025-02-19 | NCT03647852 | |
| Rituximab in the First Episode of Paediatric Nephrotic Syndrome | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, kidney disorder, nephrosis, nephrotic syndrome, nephrotic syndrome of childhood - steroid sensitive, urinary system disorder | Not yet recruiting | Phase 3 | 2025-01-22 | NCT05850546 | |
| The Effectiveness and Safety of Resective Epilepsy Surgery for TRE | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Malformations of Cortical Development, Group I, Neoplasms, Multiple Primary, brain disorder, central nervous system disorder, central nervous system malformation, cerebral cortical dysplasia, epilepsy, hamartoma, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, tuberous sclerosis | Active, not recruiting | Not stated | 2025-01-17 | NCT04198181 | |
| Belimumab After Rituximab in Resistant Primary Juvenile SS | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, childhood acute lymphoblastic leukemia, connective tissue disorder, dry eye syndrome, eye disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, lacrimal apparatus disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, mouth disorder, musculoskeletal system disorder, neoplasm, rheumatic disorder, rheumatoid arthritis, salivary gland disorder | Recruiting | Phase 4 | 2024-05-16 | NCT06410833 |